Search Details

Word: tumors (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...happened, Bradfield's tumor cells had a characteristic present in about 30% of breast-cancer cells: too many copies of a gene known as HER-2/neu. This gene makes a protein that helps relay the signal telling cells to divide. Having too much of it is associated with an especially rampaging, hard-to-treat cancer. Once this form of breast cancer metastasizes, a patient typically has just six to 12 months to live...

Author: /time Magazine | Title: Molecular Revolution | 5/18/1998 | See Source »

...Folkman's techniques. They prefer a more targeted approach: selectively attacking the various molecules and biochemical signals involved in building a new blood vessel. For instance, researchers at Ixsys, a biotech company in San Diego, have developed an artificial antibody that dissolves the biochemical glue that holds a tumor's capillaries together. Indeed, one of the patients in their safety study exceeded all expectations when two of the tumors in his abdomen shrank 70%. "I've been on the drug now for over a year," says Barry Riccio, a college professor from Illinois who is suffering from a rare sarcoma...

Author: /time Magazine | Title: The Hope & The Hype | 5/18/1998 | See Source »

Other researchers are zeroing in on different targets. Some are looking at a specialized growth factor called VEGF (for vascular endothelial growth factor) that so far has been found only in the blood vessels that feed tumors. One synthetic molecule being tested at UCLA prevents VEGF from stimulating new growth by elbowing it aside and taking its place in the cell's receptors. Safety studies in more than 30 patients have so far not revealed any major side effects, although their tumors' growth was only slowed, not halted. Dr. Joseph Sparano, at Montefiore Medical Center in New York City...

Author: /time Magazine | Title: The Hope & The Hype | 5/18/1998 | See Source »

...much of one protein, too little of another, or a misshapen protein that doesn't function properly. The new generation of cancer drugs takes aim at these defective proteins, blocking them, disrupting them in myriad ways. Unlike old-fashioned chemotherapy drugs, the new substances don't poison the tumor--an approach that usually causes collateral damage to healthy cells. Instead, they aim to halt the processes that make a cancer cell act like a cancer cell in the first place...

Author: /time Magazine | Title: Molecular Revolution | 5/18/1998 | See Source »

...lymph nodes. Bradfield got the works: a double mastectomy and six months of chemotherapy, followed by radiation and then more chemo. It bought her 18 months of symptom-free life. Then one hot August night, she recalls, "I went to rub my neck, and there was a tumor about the size of a marshmallow." Bradfield was already depressed--her daughter had just died in a car accident--and she never wanted to face chemo again. "I thought I was probably going to die, and I didn't want to die bald and throwing...

Author: /time Magazine | Title: Molecular Revolution | 5/18/1998 | See Source »

Previous | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | Next